You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -196.8% | -257.6% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -8.0 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 22.3 | 19.4 |
| Price / Book value | 17.0 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 76.5% | 3.6% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | -2.6% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | 30.47 | 1.65 | 1.40p | 23.1 | 0.0 | n/a | n/a | 0.0% |
| 2018-09-30 | 0.13 | -10.15 | -7.00p | -1.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-09-30 | 3.13 | -6.33 | -3.40p | -2.4 | 0.0 | n/a | n/a | 0.0% |
| 2020-09-30 | 5.68 | -9.17 | -5.40p | -10.5 | 0.0 | n/a | n/a | 0.0% |
| 2021-09-30 | 10.03 | -21.44 | -8.40p | -10.2 | 0.0 | n/a | n/a | 0.0% |
| Encouraging Data on Porcupine and ROCK Inhibitors | 27-Jun-22 07:00 |
|---|---|
| Interim Results for the Six Months Ended 31 March | 23-Jun-22 07:00 |
| Redx to Present at the ECM Congress | 20-Jun-22 07:00 |
| Notice of Interim Results | 16-Jun-22 07:00 |
| Pan-RAF Inhibitor to Enter Clinical Development | 15-Jun-22 07:59 |